| Ytd | 54.51% | |
| 1y | -44.97% |
| Open | 0.93 | Prev Close | 0.91 | Low | 0.92 | High | 0.99 | Mkt Cap | 47.61M |
| Vol | 704.63K | Avg Vol | 6.80M | EPS | -0.73 | P/E | N/A | Forward P/E | -0.86 |
| Beta | 0.41 | Short Ratio | 2.09 | Inst. Own | 72.62% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-30 | 50-d Avg | 0.77 | 200-d Avg | 0.65 | 1yr Est | 12.00 |
LITE, HOWL, PERI, GSBD and GFF have been added to the Zacks Rank #1 (Strong Buy) List on October 9th
Gainers Werewolf Therapeutics (NASDAQ:HOWL) shares increased by 108.1% to $0.9 during Friday's
Dow gains 400 points, Materials sector up 2.3%, Werewolf Therapeutics up 113%, S&P PMI rises to
US stocks rise, Dow gains over 350 points as markets open Friday; Materials sector up 2%, utilitie
Werewolf Therapeutics and Ambros Therapeutics merge in an all-stock deal with $150M in financing to
Werewolf Therapeutics surged after announcing a $500 million merger with Ambros Therapeutics, puttin
Gainers Werewolf Therapeutics (NASDAQ:HOWL) shares moved upwards by 74.6% to $0.75 during Friday
Ross Stores beats estimates with Q2 financial results, shares jump 9.1%. Other gainers include RFAI,
Werewolf Therapeutics shares surge 89.94% after hours as $33 million deal with EMD Serono brings fre
Gainers Werewolf Therapeutics (NASDAQ:HOWL) stock moved upwards by 77.1% to $0.76 during Thursday&#
Gainers P3 Health Partners (NASDAQ:PIII) shares increased by 24.1% to $15.92 during Monday's af
Werewolf Therapeutics (NASDAQ:HOWL) reported quarterly earnings of $0.08 per share which beat the an
Gainers Tenet Healthcare (NYSE:THC) stock increased by 17.3% to $233.54 during Friday's regular
Shares of elf Beauty Inc (NYSE: ELF) rose sharply in pre-market trading after beating analyst expect
Werewolf Therapeutics (NASDAQ:HOWL) reported quarterly losses of $(0.28) per share which met the ana
Werewolf Therapeutics (NASDAQ:HOWL) reported quarterly losses of $(0.20) per share which beat the an
Werewolf Therapeutics, Inc. (Nasdaq: HOWL) (the "Company" or "Werewolf"), an innovat
HC Wainwright & Co. analyst Andres Y. Maldonado maintains Werewolf Therapeutics (NASDAQ:HOWL)
B of A Securities analyst Jason Zemansky maintains Werewolf Therapeutics (NASDAQ:HOWL) with a Buy
Novel INDUCER™ T Cell Engager Platform designed to mitigate systemic toxicitiesSequential dosing of
Wednesday saw 219 companies set new 52-week lows.
Tuesday's session saw 167 companies set new 52-week lows.
OnThursday, 137 stocks made new 52-week lows.
On Thursday, 111 stocks hit new 52-week lows.
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 93.1% to close at $6.45 on Tuesday
Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 64.4% to close at $1.41 on Thursday.
On Thursday, 112 stocks made new 52-week lows.
Tuesday's session saw 52 companies set new 52-week lows.
Thursday saw 34 companies set new 52-week lows.
On Wednesday, 90 companies set new 52-week lows.
On Monday, 524 stocks hit new 52-week lows.
Gainers Vertex Energy, Inc. (NASDAQ: VTNR) shares climbed 124.2% to settle at $3.99 on Thursday a